Anna Wurtz

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Genetic determinants of EGFR -Driven Lung Cancer Growth and Therapeutic Response In Vivo”.

Genetic determinants of EGFR -Driven Lung Cancer Growth and Therapeutic Response In Vivo

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.13.036921

N/A

0DataRank · unranked

3 citations

Chuan Li, Hongchen Cai, Jessica A. Hellyer, Wen-Yang Lin, Deborah Ayeni +15 more

Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1385

N/A

0DataRank · unranked

122 citations

Chuan Li, Hongchen Cai, Jessica A. Hellyer, Wen-Yang Lin, Deborah Ayeni +15 more

Efficacy of osimertinib in patients with EGFR mutant lung cancer harboring the uncommon exon 19 deletion, L747_A750>P.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21112

N/A

0DataRank · unranked

0 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Anna Wurtz, Zofia Piotrowska, Andrew J. Piper‐Vallillo +13 more

Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer

Cancer Cell(2023)10.1016/j.ccell.2023.07.005

N/A

0DataRank · unranked

109 citations

Claudia Gentile, William W. Feng, Shannon J. Silva, Akshay Sankar, Francisco Expósito +21 more

Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.10.001

N/A

0DataRank · unranked

60 citations

Michael J. Grant, Anna Wurtz, Giorgia Foggetti, Francisco Expósito, Jianlei Gu +11 more

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3497

N/A

0DataRank · unranked

40 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Paul Stockhammer, Iris K. van Alderwerelt van Rosenburgh, Anna Wurtz +16 more

Association of alterations in multiple tumor suppressor genes with poor outcomes in patients with EGFR-mutant lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9104

N/A

0DataRank · unranked

1 citations

Michael J. Grant, Anna Wurtz, Giorgia Foggetti, Francisco Expósito, Jianlei Gu +7 more

ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts

Cancer Research(2024)10.1158/0008-5472.can-23-0438

N/A

0DataRank · unranked

24 citations

Marc Wiesehöfer, Fernando J. de Miguel, Zongzhi Liu, Lok-Hei Chan, Jungmin Choi +15 more